Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis.
about
A balancing act: efflux/influx in mycobacterial drug resistanceEvaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic reviewMolecular characterization of tlyA gene product, Rv1694 of Mycobacterium tuberculosis: a non-conventional hemolysin and a ribosomal RNA methyl transferaseWhole genome sequencing based characterization of extensively drug-resistant Mycobacterium tuberculosis isolates from PakistanRapid first- and second-line drug susceptibility assay for Mycobacterium tuberculosis isolates by use of quantitative PCR.The future of molecular diagnostics for drug-resistant tuberculosis.New Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in MycobacteriaInterplay between Mutations and Efflux in Drug Resistant Clinical Isolates of Mycobacterium tuberculosisMolecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from China.The antituberculosis antibiotic capreomycin inhibits protein synthesis by disrupting interaction between ribosomal proteins L12 and L10.Polymorphisms associated with resistance and cross-resistance to aminoglycosides and capreomycin in Mycobacterium tuberculosis isolates from South Korean Patients with drug-resistant tuberculosis.Molecular characterization of amikacin, kanamycin and capreomycin resistance in M/XDR-TB strains isolated in Thailand.Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates.Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis.Characterization of extensively drug-resistant Mycobacterium tuberculosis isolates circulating in SiberiaExtensively Drug-Resistant Tuberculosis: A Sign of the Times and an Impetus for Antimicrobial Discovery.Molecular basis for the selectivity of antituberculosis compounds capreomycin and viomycin.Detection of second-line drug resistance in Mycobacterium tuberculosis using oligonucleotide microarrays.Mycobacterium tuberculosis can utilize heme as an iron source.Transposon mutagenesis in Bifidobacterium breve: construction and characterization of a Tn5 transposon mutant library for Bifidobacterium breve UCC2003Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.Mutation detection and accurate diagnosis of extensively drug-resistant tuberculosis: report from a tertiary care center in India.Molecular epidemiology of tuberculosis: current insights.Microevolution of extensively drug-resistant tuberculosis in Russia.Analysis of IS6110 insertion sites provide a glimpse into genome evolution of Mycobacterium tuberculosis.Identification of the biosynthetic gene cluster and an additional gene for resistance to the antituberculosis drug capreomycinCorrelation between GyrA substitutions and ofloxacin, levofloxacin, and moxifloxacin cross-resistance in Mycobacterium tuberculosis.Detection of first- and second-line drug resistance in Mycobacterium tuberculosis clinical isolates by pyrosequencing.Molecular characterization of multidrug- and extensively drug-resistant Mycobacterium tuberculosis strains in Jiangxi, China.Capreomycin susceptibility is increased by TlyA-directed 2'-O-methylation on both ribosomal subunits.QSAR based therapeutic management of M. tuberculosis.Importance of the genetic diversity within the Mycobacterium tuberculosis complex for the development of novel antibiotics and diagnostic tests of drug resistanceTriplex real-time PCR melting curve analysis for detecting Mycobacterium tuberculosis mutations associated with resistance to second-line drugs in a single reaction.Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistance.Drug-Resistant Tuberculosis: Challenges and Progress.Performance of the New Version (v2.0) of the GenoType MTBDRsl Test for Detection of Resistance to Second-Line Drugs in Multidrug-Resistant Mycobacterium tuberculosis Complex Strains.Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis: epidemiology and control.Mutations in conserved helix 69 of 23S rRNA of Thermus thermophilus that affect capreomycin resistance but not posttranscriptional modificationsInactivation of KsgA, a 16S rRNA methyltransferase, causes vigorous emergence of mutants with high-level kasugamycin resistance.Prevalence and genetic characterization of second-line drug-resistant and extensively drug-resistant Mycobacterium tuberculosis in Rural China.
P2860
Q24644870-F7BF6B69-35C1-4FBB-8EE4-84EFF2F6C5E0Q28481845-04A52917-BDCE-4CCF-86C2-5382715F5580Q28487620-3E72DFD6-92B4-4E7A-830B-9DA94563FE66Q28543682-72BC80F6-8E39-43F4-889B-59AECA16016FQ30431597-B78692CB-BF6F-46EC-BC12-0C4B95BA266DQ30455525-9F3B555A-BF56-425B-B4E1-92CE81DB2A44Q33600161-3A4B64C1-D79E-41BC-BE20-E5E1B57CE067Q33607162-AC1D1187-A873-4984-B3D7-E6ADB5B4FE56Q33622808-229175AC-A2A6-4D5F-AC3D-B572B4873668Q33622886-E2D20194-C410-46BB-9615-CF456EAB4C0AQ33627296-E8372F87-BF50-47E7-AFB4-969AFFFB07C6Q33826477-7A433F93-DD23-44D1-954C-719D22ABBE2FQ33827163-8D8C6D0A-8057-4938-8FDF-1A51DF3D4ACAQ33938148-53E91E58-ED5A-4C98-AEDC-C24134DABA3DQ34168756-FB8EB6BA-3F37-463B-80E0-20B7263136C2Q34410451-7CBEA762-6E46-4DB1-86F5-A0CC60A7C71DQ34631045-D3439AAF-3F6C-407B-9A95-403A5D7A1B25Q34738488-7C3F6325-C287-47C0-B85A-D3671C5DA36EQ34740822-EB80795A-6C51-4B9F-BAF1-A89A8835389FQ34758875-A923E33D-2759-46F9-BC08-84FC7E0DB969Q34933405-FEB714D0-F54D-4DC1-898C-AE37849184D2Q35067024-37AF56BB-0A63-4E84-B07F-EFED486FBFFAQ35070843-54C570AD-BB54-4F77-8C40-535493679EEEQ35864738-113DF254-1114-4F17-9D46-A07ADE279DF3Q35895386-F06B827F-AF0F-492F-BD45-72F154A6A917Q35913280-75A2BABA-84AD-4F1D-8D61-3DB6972BB16DQ35960685-B3AFC694-3210-43BD-8FD5-076C384880FDQ36022970-F50A46A5-45CE-44A6-95EB-E78D7E9E0069Q36118776-05DC0EAD-396B-455C-9D02-9C417AFC442DQ36223145-076A0578-D4C9-4AFC-A752-D8C2693C112DQ36359056-43C26851-0F38-48AD-B3F0-81140BEA08B0Q36396241-1E9B359A-5AE4-4618-8A17-E841BDEFC88FQ36762984-95C34CC8-74A6-485D-8B8D-AD39CCAA3033Q36844683-B228F340-4D5A-4E34-B6BF-5DF77FF7C136Q36924283-33982C14-D098-4CE6-B536-FA266AEDACD4Q36933151-4BA360E7-1AB5-4815-889D-1E829413C431Q36960077-6324A18C-F69E-411C-B6DC-29DBB20A6650Q36974601-6A953FEF-5C64-432E-B122-BB069F425D90Q37032849-0BAA7590-86A2-47EE-A23F-95380AD6D142Q37036485-E50A58F2-BF53-4BDE-847D-F372DED06A71
P2860
Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis.
@ast
Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis.
@en
type
label
Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis.
@ast
Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis.
@en
prefLabel
Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis.
@ast
Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis.
@en
P2093
P2860
P1476
Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis.
@en
P2093
Bonnie B Plikaytis
Courtney E Maus
Thomas M Shinnick
P2860
P304
P356
10.1128/AAC.49.2.571-577.2005
P407
P577
2005-02-01T00:00:00Z